REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $885 | -68.1% | 77,200 | -10.4% | 0.00% | -75.0% |
| Q1 2023 | $2,775 | -98.2% | 86,155 | +676.2% | 0.00% | – |
| Q2 2022 | $153,000 | -52.6% | 11,099 | -33.1% | 0.00% | – |
| Q1 2022 | $323,000 | -20.8% | 16,583 | -33.8% | 0.00% | – |
| Q4 2021 | $408,000 | +2300.0% | 25,048 | +4131.1% | 0.00% | – |
| Q2 2021 | $17,000 | -94.7% | 592 | -94.8% | 0.00% | – |
| Q1 2021 | $320,000 | -29.8% | 11,456 | -28.9% | 0.00% | -100.0% |
| Q4 2020 | $456,000 | – | 16,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |